Martin W. Brechbiel - Concepedia

Author

Martin W. Brechbiel

Also Known As

Brechbiel, M. W., Brechbiel, M.W., Brechbiel, Martin W., Cyrille Alliot, M BRECHBIEL, M Brechbiel, M W Brechbiel, M. BRECHBIEL, M. Brechbiel, M. W. BRECHBIEL

481

Publications

23.2K

Citations

H-Index

208

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institutes of Health Clinical Center University of New Hampshire

About

Martin W. Brechbiel is an author at National Cancer Institute specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	111	7.2K
2	Engineering	37	64	4.4K
3	Natural Sciences	25	41	1.9K
4	Health Sciences	17	17	943
5	Allergy	5	5	112

Martin W. Brechbiel

293

Publications

18.7K

Citations

H-Index

Page 1

	Year	Citations
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents Erik C. Wiener, Martin W. Brechbiel, Herbert M. Brothers, Magnetic Resonance in Medicine	1994	711
Targeted α particle immunotherapy for myeloid leukemia Joseph G. Jurcic, Steven M. Larson, George Sgouros, Blood	2002	465
Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies Martin W. Brechbiel, Otto A. Gansow, Robert W. Atcher, Inorganic Chemistry Altmetric Attention ScoreChemical DerivativeTumor BiologyMedicinal ChemistryRadiopharmaceutical Therapy	1986	288
Dendrimer-Based Nanoprobe for Dual Modality Magnetic Resonance and Fluorescence Imaging Vladimir S. Talanov, Celeste A.S. Regino, Hisataka Kobayashi, Nano Letters NanoparticlesNanomedicineEngineeringMagnetic Resonance SpectroscopyImaging Agent	2006	266
Macromolecular MRI Contrast Agents with Small Dendrimers: Pharmacokinetic Differences between Sizes and Cores Hisataka Kobayashi, Satomi Kawamoto, Sang-Kyung Jo, Bioconjugate Chemistry EngineeringImaging AgentPharmacokinetic DifferencesBiomedical EngineeringRapid Excretion	2003	257
Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates L. Henry Bryant, Martin W. Brechbiel, Chuanchu Wu, Journal of Magnetic Resonance Imaging Combinatorial ChemistryEngineeringBiochemistryNatural SciencesOrganic Chemistry	1999	232
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt, Proceedings of the National Academy of Sciences ImmunologyDermatologyImmunotherapyUnique EpitopeTumor Biology	2007	217
Targeting Dendrimer-Chelates to Tumors and Tumor Cells Expressing the High-Affinity Folate Receptor Erik C. Wiener, Sheela D. Konda, Amber Shadron, Investigative Radiology	1997	210
Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts Sheela D. Konda, Michael Aref, Steven Wang, Magnetic Resonance Materials in Physics Biology and Medicine EngineeringMedicineImaging AgentTheranosticsTumor Targeting	2001	207
Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Kazuo Shirakawa, Hisataka Kobayashi, Yuji Heike, PubMed Breast OncologyImmunologyPathologyTumor BiologyBlood Flow	2002	207

Page 1